A new pathogenic mutation in the APP gene (1716V) increases the relative proportion of Aβ42(43)

Human Molecular Genetics

Volumn 6, Issue 12, 1997, Pages 2087-2089

  Eckman, Christopher B ^a,b   Mehta, Nitin D ^a,c   Crook, Richard ^a,c   Perez tur, Jordi ^a,c   Prihar, Guy ^a,c   Pfeiffer, Eric ^c   Graff Radford, Neill ^a   Hinder, Paul ^a   Yager, Debra ^a   Zenk, Brenda ^a   Refolo, Lawrence M ^a   Prada, Cristian Mihail ^a   Younkin, Steven G ^a   Hutton, Mike ^a,c   Hardy, John ^a,c  

^a MAYO CLINIC   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; COMPLEMENTARY DNA;

ALZHEIMER DISEASE; ARTICLE; DNA TRANSFECTION; FAMILIAL DISEASE; GENE MUTATION; HUMAN; ONSET AGE; PRIORITY JOURNAL;

AGE OF ONSET; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; FEMALE; HUMANS; MIDDLE AGED; PEPTIDE FRAGMENTS; POINT MUTATION;

EID: 9844261165     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/6.12.2087     Document Type: Article

References (17)

1. Hardy,J. (1997) Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154-159.
2. Younkin,S. (1997) Evidence that Aβ42 is the real culprit in Alzheimer's disease. Ann. Neurol. 37, 287-288.
3. Scheuner,D., Eckman,C., Jensen,M., Song,X., Citron,M., Suzuki,N., Bird,T.D., Hardy,J., Hutton,M., Kukull,W., Larson,E., Levy-Lahad,E., Viitanen,M., Peskind,E., Poorkaj,P., Schellenberg,G., Tanzi,R., Wasco,W., Lannfelt,L., Selkoe,D. and Younkin,S. (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864-870.
4. Duff,K., Eckman,C., Zehr,C., Yu,X., Prada,C.M., Perez-tur,J., Hutton,M., Buee,L., Harigaya,Y., Yager,D., Morgan,D., Gordon,M.N., Holcomb,L., Refolo,L., Zenk,B., Hardy,J. and Younkin,S. (1996). Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710-713.
5. Borchelt,D.R., Thinakaran,G., Eckman,C.B., Lee,M.K., Davenport,F., Ratovitsky,T., Prada,C.-M., Kim,G., Seekins,S., Yager,D., Slunt,H., Wang,R., Seeger,M., Levey,A.I., Gandy,S.E., Copeland,N.G., Jenkins,N.A., Price,D.L., Younkin,S.G. and Sisodia,S.S. (1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 17, 1005-1013.
6. Citron,M., Westaway,D., Xia,W., Carlson,G., Diehl,T., Levesque,G., Johnson-Wood,K., Lee,M., Seubert,P., Davis,A., Kholodenko,D., Motter,R., Sherrington,R., Perry,B., Yao,H., Strome,R., Lieberburg.I., Rommens,J., Kim,S., Schenk,D., Fraser,P., St George Hyslop,P. and Selkoe,D.J. (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nature Med. 3, 67-72.
7. Tomita,T., Maruyama,K., Saido,T.C., Kume,H., Shinozaki,K., Tokuhiro,S., Capell,A., Walter,J., Grunberg,J., Haass,C., Iwatsubo,T. and Obata,K. (1997). The presenilin 2 mutation (N1411) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue. Proc. Natl. Acad. Sci. USA 94, 2025-2030.
8. Suzuki,N. et al. (1994) An increased percentage of long amyloid β protein secreted by familial amyloid β protein (βAPP717) mutants. Science 264, 1136-1140.
9. Folstein,M.F., Folstein,S.E. and McHugh,P.R. (1975) 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J. Psychiat. Res. 12, 189-198.
10. Goodglass,H., Kaplan,E. and Weintraub,S. (1983) The Boston Naming Test. Lea and Febiger, Philadelphia, PA.
11. Mattis,S. (1983) Dementia Rating Scale. Psychological Assessment Resources, Odessa.
12. Weschler,D. (1987) Weschler Memory Scale-Revised. The Psychological Corporation, New York.
13. Benton,A.L. and Hamsher,K. (1983) Multilingual Aphasia Examination. AJA Associates, Iowa City.
14. Warrington,E. (1984) Recognition Memory Test. NFER-Nelson, Windsor, UK.
15. McKhann,G.M., Drachman,D., Folstein,M.F. et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
16. Mullan,M., Tsuji,S., Miki,T., Katsuya,T., Naruse,S., Kaneko,K., Shimizu,T., Kojima,T., Nakano,I., Ogihara,T., Miyatake,T., Ovenstone,S., Crawford,F., Goate,A., Hardy,J., Roques,P., Rossor,M., Roberts,G., Luthert,P., Lantos,P., Clark,C., Gaskell,P., Crain,B. and Roses,A. (1993) Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val-→Ile mutation in the amyloid precursor protein gene. Neurobiol. Aging 14, 407-419.
17. Odaka, A. et al. (1995) Long amyloid b-protein secreted from wild-type human neuroblastoma IMR32 cells. Biochemistry 34, 10272-10278.